A use is disclosed for blocking or reducing physiological reaction in a mammalto theinteraction of IgE antibodies present in said mammal upon contact with thecorrespondingantigen, by the administration to said mammal of a therapeutically effectiveamount of aneurotoxin (CnT) derived from Clostridia sp.